Invested in Ouro Medicines to advance autoimmune therapies through T-cell engagers and B-cell depletion.
Ouro Medicines is focused on developing therapies for chronic immune-mediated diseases, leveraging scientific expertise and a robust pipeline of cell-depleting therapies
Ouro Medicines is focused on developing therapies for chronic immune-mediated diseases, leveraging scientific expertise and a robust pipeline of cell-depleting therapies.